Pressurized Meter Dose Inhaler V/S Dry Powder Inhaler
Starting soon · Not applicable
Conditions studied: Asthma (Diagnosis)
In brief
This study compares two commonly used inhalation devices in asthma management. It focuses on evaluating how effectively PMDIs and DPIs deliver the same combination of inhaled corticosteroids and long-acting beta agonists in patients whose asthma remains poorly controlled despite treatment. The study is conducted in a tertiary care hospital setting, emphasizing real-world clinical practice and aiming to determine whether device choice influences asthma control outcomes.
Key facts
- Study ID
- NCT07372573
- Run by
- University of Health Sciences Lahore
- People needed
- 210
- Starts
- 2026-02-01
- Expected to finish
- 2026-07-31
- Last updated by the study team
- 2026-01-28
Who can join
Age: 14 and older, up to 60. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 14 to 60 years
- Both genders
- All patients with symptoms of uncontrolled asthma
You may not qualify if…
- Patients with coexistent fungal sensitization (confirmed with peripheral eosinophil count and serum IgE)
- Patients with coexistent Allergic Bronchopulmonary Aspergillosis (ABPA) (confirmed with HRCT and serum IgE)
- Patients with coexistent COPD (confirmed on spirometry)
- Patients with Hypersensitivity Pneumonitis
- Patients with coexistent Interstitial Lung Disease (ILD) (confirmed on spirometry)
- Patients with coexistent cardiac asthma secondary to heart failure (diagnosed on echocardiography)
Where it is running
- Services Hospital Lahore — Lahore, Punjab Province, Pakistan
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.